Our strategic partnership with Novo Nordisk expands today as they announce that they've chosen AWS as their preferred cloud provider and strategic AI partner to help accelerate drug discovery. We will combine Novo Nordisk’s scientific expertise with AWS’s AI tools, including Amazon Bio Discovery (biology AI models to design and test drug candidates) and Bedrock AgentCore (infrastructure for building AI agents that run real workflows), and also stand up a co-innovation hub in London where their scientists and our engineers work side by side. We’re proud of our broad partnership across the two companies, which already spans AWS, Amazon Pharmacy, and One Medical. I’m optimistic about how we’ll use AI together to speed up drug discovery, and what that will mean for patients.